Clinical Trial Update: Effects of Antiviral Therapies on Epstein-Barr Virus Replication [Phase 2]

View source ↗

Summary

Phase 2 clinical trial from Massachusetts General Hospital evaluating antiviral therapies to suppress Epstein-Barr virus replication in people with multiple scl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Multiple Sclerosis | Phase 2 | Status: ENROLLING_BY_INVITATION